Current and potential application of GnRH agonists in gynecologic practice

Annals of the New York Academy of Sciences

Volumn 900, Issue , 2000, Pages 435-443

  Tzafettas, John M ^a,b  

^a Hippokration General Hospital   (Greece)

^b FRCOG   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST;

ANOVULATION; BONE ATROPHY; BONE MASS; BREAST CANCER; CONFERENCE PAPER; DRUG SAFETY; EMBRYO TRANSFER; ENDOMETRIOSIS; ENDOMETRIUM CANCER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HYSTEROSCOPY; OVARY POLYCYSTIC DISEASE; PRECOCIOUS PUBERTY; UTERUS BLEEDING; UTERUS MYOMA;

EID: 0034059425     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06258.x     Document Type: Conference Paper

References (42)

1. 1. NIESERT, S. 1996. Leuproelin, an exciting development in the treatment of gynaecological disorders. Hormone Ther. Obstet. Gynecol. 1: 4-9.
2. 2. REISSMAN, T., R. FELDERBAUM, K. DIEDRICH et al. 1995. Development and applications of LHRH antagonists in the treatment of infertility: an overview. Hum Reprod. 10: 1974-1979.
3. 3. WORD, R.A., M.J. ODOM, W. BYRD & B.R. CARR. 1990. The effect of GnRH-a on growth hormone secretion in adult premenopausal women. Fertil. Steril. 54: 73-78.
4. 4. WILSON, E.E., B.B. LITTLE, W. BYRD et al. 1993. The effect of GnRH-a on adrenocorticotropin and cortisol secretion in adult premenopausal women. J. Endocrinol. Metab. 76: 162-164.
5. 5. VARCELLINI, P., P.G. CROSIGNANI, C. MANGIONI et al. 1998. Treatment with a gonadotrophin releasing hormone agonist before hysterectomy for leiomyomas: results of a multicentre, randomised controlled trial. Br. J. Obstet. Gynaecol. 105: 1148-1154.
6. 6. MATTA, W.H.M., I. STABILE, R.W. SHAW & S. CAMBELL. 1988. Doppler assessment of uterine blood flow changes in patients with fibroids receiving the GnRH-a buserelin. Fertil. Steril. 49:1083-1085.
7. 7. ALEEM, F.A. & M. PREDANIC. 1955. The hemodynamic effect of GnRH-a therapy on uterine leiomyoma vascularity:a prospective study using transvaginal color doppler sonography. Gynecol. Endocrinol. 9: 253.
8. 8. COHEN, D., M.T. MAZUR, M.A. JOZEFCZYK & S.Z.A. BADAWY. 1994. Hyalinization and cellular changes in uterine leiomyomata after GnRH-a therapy. J. Reprod. Med. 39: 377-380.
9. 9. REIN, M.S., A.J. FRIEDMAN, M.R. PANDIAN & L.J. HEFFNER. 1990. The secretion of IGF-I and II by explant cultures of fibroids and myometrium from women treated with GnRH agonist. Obstet. Gynecol. 76: 388-394.
10. 10. HOUSTON, D.E. 1984. Evidence for the risk for pelvic endometriosis by age, race and socioeconomic status. Epidemiol. Rev. 6: 167-191.
11. 11. GUERRERO, H.E., P. STEIN, R.H. ASCH et al. 1993. Effect of a GnRH-a on LH receptors and steroidogenesis in ovarian cells. Fertil. Steril. 59: 803-809.
12. 12. WRIGHT, J.A. & K.L. SHARPE-TIMMS. 1995. GnRH-a therapy reduces postoperative adhesion formation and reformation after adhesiolysis in rat models for adhesion formation and endometriosis. Fertil. Steril. 63: 1094-1100.
13. 13. BERGQVIST, I.A. 1995. Hormonal endometriosis and the rationales and effects of GnRH-a treatment: a review. Hum Reprod. 10: 446-452.
14. 14. SAKATA, M., S. OHTSUKA, H. KURATSI et al. 1994. The hypothalamic-pituitary-ovarian axis in patients with endometriosis, is suppressed by leuprolide acetate but not by danazol. Fertil. Steril. 61: 431-437.
15. 15. VARCELLINI, P., A. PISACRETA, O. DE GIORGI et al. 1998. Management of advanced endometriosis. In Fertility and Reproductive Medicine. R.D. Kempers, J. Cohen, A.F. Haney & J.B. Younger, Eds. :369-386. Excerpta Medica.
16. 16. WHEELER, J.M., J.D. KNITTLE & J.D. MILLER. 1993. Depot leuprolite acetate versus danazol in the treatment of women with symptomatic endometriosis, a multicenter double-blind randomized clinical trial. II. Assessment of safety. Am. J. Obstet. Gynecol. 169: 26-33.
17. 17. WHEELER, J.M., J.D. KNITTLE & J.D. MILLER. 1992. Depot leuprolide versus danazolin treatment of women with symptomatic endometriosis. I. Efficacy results. Am. J. Obstet. Gynecol. 167: 1367-1371.
18. 18. FILICORI, M. 1997. Leuprorelin: increasing its role in the management of endometriosis. Obstet. Gynecol. 2: 4-10.
19. 19. DONNEZ, J., M. NISOLLE, F. CLERCKX et al. 1994. Advanced endoscopic techniques used in dysfunctional bleeding, fibroids and endometriosis and the role of GnRH agonist treatment. Br. J. Obstet. Gynaecol. 101: 2-12.
20. 20. AMERICAN FERTILITY SOCIETY. 1995. Revised American Fertility Society classification of endometriosis: 1995. Fertil. Steril. 43: 351-352.
21. 21. AHMED, M.S. & R.L. BARBIERI. 1977. Reoperation rates for recurrent ovarian endometriomas after surgical excision. Gynecol. Obstet. Invest. 43: 53-54.
22. 22. EVERS, J.L.H. 1987. The 2nd look laparoscopy for evaluation of the result of medical treatment of endometriosis should not be performed during ovarian suppression. Fertil. Steril. 47: 502-504.
23. 23. CANDIANI, G.B., P. VARSELLINI, L. FEDELE et al. 1990. Use of goserelin depot, a GnRH agonist, for the treatment of menorrhagia and severe anemia in women with leiomata uteri. Acta Obstet. Gynecol. Scand. 69: 413-415.
24. 24. KE, R.W. & P.J. TAYLOR. 1991. Endometrial ablation in the treatment of excessive uterine bleeding. Hum. Reprod. 6: 574-576.
25. 25. LOUMAYE, E. 1990. The control of endogenous gonadotropin secretion with GnRH-a during ovarian hyperstimulation for IVF-ET. Hum. Reprod. 5: 357-361.
26. 26. TAN, S.L., N. MACONOCHIE, P. DOYLE et al. 1994. Cumulative conception live birth rate after IVF-ET with and without the use of short, long or ultrashort regimen of the GnRH-a buserelin. Am. J. Obstet. Gynecol. 171: 513-516.
27. 27. DAYA, S. & J. GANBY. 1994. The effectiveness of allogeneic immunization in unexplained primary recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group. Am. J. Reprod. Immunol. 32: 294-302.
28. 28. THE GERMAN RECURRENT SPONTNEOUS ABORTION/INTRAVENOUS IMMUNOGLOBULIN GROUP. 1994. Intravenous immunoglobulin in the prevention of recurrent miscarriage. Br. J. Obstet. Gynaecol. 101: 1072-1077.
29. 29. ROYAL COLLEGE OF OBSTETRICIANS AND GYNAECOLOGISTS. 1998. The management of recurrent miscarriage. Guideline No 17. London, UK.
30. 30. EMONS, G. & A.V. SCHALLY. 1994. The use of GnRH agonists and antagonists in gynecological cancers. Hum. Reprod. 9: 1364-1379.
31. 31. EMONS, G., O. ORTMANN & K.D. SCHULZ. 1996. GnRH-a in ovarian, breast and endometrial cancer. In GnRH Analogues, The State of the Art 1996. B. Lunenfeld & V. Insler, Eds. :95-120. Parthenon Publishing. Carnforth. UK.
32. 32. DOWSETT, M., S. JACOBS, J. ATHERNE & J.E. SMITH. 1992. Clinical and endocrine effects of leuprorelin acetate in pre and post-menopausal patients with advanced breast cancer. Clin. Ther. 14: 97-103.
33. 33. EMONS, G., O. ORTMANN, G. IRMER et al. 1996. Treatment of ovarian cancer with LH-RH antagonists. In Treatment with GnRH-a: Controversies and Perspectives. M. Filicori & C. Flamigni, Eds.: 165-172. Parthenon. Carnforth. UK.
34. 34. CULLANDER, S. 1992. Treatment of endometrial cancer with GnRH analogs. Recent results. Cancer Res. 124: 69-73.
35. 35. ATAYA, K., L.V. RAO, E. LAWRENCE & R. KIMMEL. 1995. LHRH agonist inhibit cyclophosphamide-induced ovarian follicular depletion in Rhesus monkeys. Biol. Reprod. 52: 365-372.
36. 36. FRIEDMAN, A.J., S.M. LOBEL, M.S. REIN & R.L. BARBIERI. 1990. Efficacy and safety considerations in women with uterine leiomyomas treated with GnRH-a: the estrogen threshold hypothesis. Am. J. Obstet. Gynecol. 163: 1114-1119.
37. 37. BARBIERI, R.L. 1992. Hormone treatment of endometriosis: the estrogen threshold hypothesis. Am. J. Obstet. Gynecol. 166: 740-745.
38. 38. REGIDOR, P.A., M. REGIDOR, K. KATO et al. 1997. Long-term follow-up on the treatment of endometriosis with the GnRH-a buserelin acetate. Eur. J. Obstet. Gynecol. Reprod. Biol. 73: 153-160.
39. 39. FRIEDMAN, A.J., R.L. BARBIERI, P.M. DOUBLET et al. 1988. A randomized double-blind trial of a GnRH-a (leuproralide) with or without metroxyprogesterone acetate in the treatment of leiomyomata uteri. Fertil. Steril. 49: 404-409.
40. 40. FRIEDMAN, A. & M.D. HORSTEIN. 1993. GnRH-a plus estrogen/progestin "add-back" therapy for endometriosis-related pelvic pain. Fertil. Steril. 60: 236-243.
41. 41. TAKAYAMA, K., K. ZEITOUN, R.T. GUNBY et al. 1998. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil. Steril. 69: 709-713.
42. 42. PICKERSGILL, A. 1998. GnRH-a and add-back therapy: is there a perfect combination? Br. J. Obstet. Gynaecol. 105: 475-485.